IGF-I contributes to glucose homeostasis in the Berlin Fat Mouse Inbred line

References

• Adamo ML, Ma X, Ackert-Bicknell CL, Donahue LR, Beamer WG, Rosen CJ. 2006. Genetic increase in serum insulin-like growth factor-I (IGF-I) in C3H/HeJ compared with C57BL/6J mice is associated with increased transcription from the IGF-I exon 2 promoter. Endocrinology. 147:2944–2955.
   PubMed Web of Science ®Google Scholar
• Ajuwon KM, Kuske JL, Ragland D, Adeola O, Hancock DL, Anderson DB, Spurlock ME. 2003. The regulation of IGF-1 by leptin in the pig is tissue specific and independent of changes in growth hormone. J Nutr Biochem. 14:522–530.
   PubMed Web of Science ®Google Scholar
• Alexandrides T, Moses AC, Smith RJ. 1989. Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle. Endocrinology. 124:1064–1076.
   PubMed Web of Science ®Google Scholar
• Boni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. 1991. Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol. 260:E846–E851.
   PubMed Web of Science ®Google Scholar
• Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS. 1994. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest. 93:1131–1139.
   PubMed Web of Science ®Google Scholar
• Frystyk J, Brick DJ, Gerweck AV, Utz AL, Miller KK. 2009. Bioactive insulin-like growth factor-I in obesity. J Clin Endocrinol Metab. 94:3093–3097.
   PubMed Web of Science ®Google Scholar
• Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. 1995. Free insulin-like growth factors in human obesity. Metabolism. 44:37–44.
   PubMed Web of Science ®Google Scholar
• Hantschel C, Wagener A, Neuschl C, Teupser D, Brockmann GA. 2011. Features of the Metabolic Syndrome in the Berlin Fat Mouse as a Model for Human Obesity. Obes Facts. 4.
   PubMed Web of Science ®Google Scholar
• Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM. 2006. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp Clin Endocrinol Diabetes. 114:371–376.
   PubMed Web of Science ®Google Scholar
• Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3–34.
   PubMed Web of Science ®Google Scholar
• Kratzsch J, Blum WF, Schenker E, Keller E, Jahreis G, Haustein B, Ventz M, Rotzsch W. 1993. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay. Exp Clin Endocrinol. 101:144–149.
   PubMedGoogle Scholar
• LeRoith D, Werner H, Beitner-Johnson D, Roberts CTJr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 16:143–163.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
   PubMed Web of Science ®Google Scholar
• Loche S, Cappa M, Borrelli P, Faedda A, Crino A, Cella SG, Corda R, Muller EE, Pintor C. 1987. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol (Oxf). 27:145–153.
   PubMed Web of Science ®Google Scholar
• Maccario M, Ramunni J, Oleandri SE, Procopio M, Grottoli S, Rossetto R, Savio P, Aimaretti G, Camanni F, Ghigo E. 1999. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord. 23:612–618.
   PubMed Web of Science ®Google Scholar
• Meyer CW, Wagener A, Rink N, Hantschel C, Heldmaier G, Klingenspor M, Brockmann GA. 2009. High energy digestion efficiency and altered lipid metabolism contribute to obesity in BFMI mice. Obesity (Silver Spring). 17:1988–1993.
   PubMed Web of Science ®Google Scholar
• Moller DE, Yokota A, Caro JF, Flier JS. 1989. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol. 3:1263–1269.
   PubMed Web of Science ®Google Scholar
• Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA. 1990. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J. 9:2409–2413.
   PubMed Web of Science ®Google Scholar
• Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. 1997. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 21:355–359.
   PubMed Web of Science ®Google Scholar
• Nam SY, Marcus C. 2000. Growth hormone and adipocyte function in obesity. Horm Res. 53 Suppl 1: 87–97.
   PubMedGoogle Scholar
• Neuschl C, Hantschel C, Wagener A, Schmitt AO, Illig T, Brockmann GA. 2010. A unique genetic defect on chromosome 3 is responsible for juvenile obesity in the Berlin Fat Mouse. Int J Obes (Lond). 34:1706–1714.
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Mohan S, Sjogren K, Tivesten A, Isgaard J, Isaksson O, Jansson JO, Svensson J. 2009. The role of liver-derived insulin-like growth factor-I. Endocr Rev. 30:494–535.
   PubMed Web of Science ®Google Scholar
• Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A. 2002. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem. 277:39684–39695.
   PubMed Web of Science ®Google Scholar
• Petersen KF, Shulman GI. 2002. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol. 90:11G–18G.
   PubMed Web of Science ®Google Scholar
• Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA. 2002. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects. Am J Physiol Endocrinol Metab. 282:E1360–E1368.
   Web of Science ®Google Scholar
• Rajaram S, Baylink DJ, Mohan S. 1997. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev. 18:801–831.
   PubMed Web of Science ®Google Scholar
• Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GY, Kaplan RC, Muzumdar R, Rohan TE, Strickler HD. 2009. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev. 25:3–12.
   PubMed Web of Science ®Google Scholar
• Reaven GM. 1988. Role of insulin resistance in human disease. Diabetes. 37:1595–1607.
   PubMed Web of Science ®Google Scholar
• Roberts CTJr., Lasky SR, Lowe WLJr., Seaman WT, LeRoith D. 1987. Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol. 1:243–248.
   PubMed Web of Science ®Google Scholar
• Russell-Jones DL, Bates AT, Umpleby AM, Hennessy TR, Bowes SB, Hopkins KD, Jackson N, Kelly J, Shojaee-Moradie F, Jones RH, . 1995. A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers. Eur J Clin Invest. 25:403–411.
   PubMed Web of Science ®Google Scholar
• Saukkonen T, Amin R, Williams RM, Fox C, Yuen KC, White MA, Umpleby AM, Acerini CL, Dunger DB. 2004. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes. J Clin Endocrinol Metab. 89:4634–4641.
   PubMed Web of Science ®Google Scholar
• Sjogren K, Jansson JO, Isaksson OG, Ohlsson C. 2002. A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I. Endocrine. 19:249–256.
   PubMed Web of Science ®Google Scholar
• Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C. 1999. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A. 96:7088–7092.
   PubMed Web of Science ®Google Scholar
• Taicher GZ, Tinsley FC, Reiderman A, Heiman ML. 2003. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem. 377:990–1002.
   PubMed Web of Science ®Google Scholar
• Tinsley FC, Taicher GZ, Heiman ML. 2004. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes Res. 12:150–160.
   PubMedGoogle Scholar
• Wagener A, Schmitt AO, Aksu S, Schlote W, Neuschl C, Brockmann GA. 2006. Genetic, sex, and diet effects on body weight and obesity in the Berlin Fat Mouse Inbred lines. Physiol Genomics. 27:264–270.
   PubMed Web of Science ®Google Scholar
• Wallenius K, Sjogren K, Peng XD, Park S, Wallenius V, Liu JL, Umaerus M, Wennbo H, Isaksson O, Frohman L, Kineman R, Ohlsson C, Jansson JO. 2001. Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology. 142:4762–4770.
   PubMed Web of Science ®Google Scholar
• Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, Williams SC, Cawthorn WP, Medina-Gomez G, Vidal-Puig A, Sethi JK, Crossey PA. 2007. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes. 56:285–294.
   PubMed Web of Science ®Google Scholar
• Woods KA, Camacho-Hubner C, Barter D, Clark AJ, Savage MO. 1997. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl. 423:39–45.
   PubMedGoogle Scholar
• Woods KA, Camacho-Hubner C, Bergman RN, Barter D, Clark AJ, Savage MO. 2000. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab. 85:1407–1411.
   PubMed Web of Science ®Google Scholar
• Xuan S, Kitamura T, Nakae J, Polit K, Kido Y, Fisher PE, Morroni M, Cinti S, White MF, Herrera PL, Accili D, Efstratiadis A. 2002. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest. 110:1011–1019.
   PubMed Web of Science ®Google Scholar
• Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D. 2001. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes. 50:1110–1118.
   PubMed Web of Science ®Google Scholar
• Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A. 96:7324–7329.
   PubMed Web of Science ®Google Scholar